F16.21
BillableHallucinogen dependence, in remission
Hallucinogen dependence, in remission
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Other hallucinogen use disorder, moderate, in early remission
- Other hallucinogen use disorder, moderate, in sustained remission
- Other hallucinogen use disorder, severe, in early remission
- Other hallucinogen use disorder, severe, in sustained remission
- Phencyclidine use disorder, moderate, in early remission
- Phencyclidine use disorder, moderate, in sustained remission
- Phencyclidine use disorder, severe, in early remission
- Phencyclidine use disorder, severe, in sustained remission
Includes
Conditions included under this code
- disorders of psychological development
- ecstasy
- PCP
- phencyclidine
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)
Also Known As / Clinical Terms
UMLS
- Hallucinogen Dependence, in RemissionC0154497
- Hallucinogen dependence in remissionC0154497
- Hallucinogen dependence in remission (disorder)C0154497
- Hallucinogen dependence, in remissionC0154497
- Other hallucinogen use disorder, moderate, in early remissionC4509072
- Other hallucinogen use disorder, moderate, in sustained remissionC4509073
- Other hallucinogen use disorder, severe, in early remissionC4509074
- Other hallucinogen use disorder, severe, in sustained remissionC4509075
- Phencyclidine use disorder, moderate, in early remissionC4481027
- Phencyclidine use disorder, moderate, in sustained remissionC4481028
- Phencyclidine use disorder, severe, in early remissionC4481029
- Phencyclidine use disorder, severe, in sustained remissionC4481030
Frequently Asked Questions
What is the ICD-10 code for hallucinogen dependence, in remission?
The ICD-10-CM code for hallucinogen dependence, in remission is F16.21. The full clinical description is "Hallucinogen dependence, in remission". F16.21 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code F16.21 mean?
ICD-10-CM code F16.21 represents "Hallucinogen dependence, in remission". It is classified under Chapter 5: Mental, Behavioral and Neurodevelopmental Disorders and is a billable/specific code that can be used on a claim.
Is F16.21 a billable code?
Yes, F16.21 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is F16.21 in?
F16.21 is in Chapter 5: Mental, Behavioral and Neurodevelopmental Disorders (codes F01-F99).
What codes cannot be used with F16.21?
F16.21 has Excludes1 notes indicating codes that cannot be used together with it, including: hallucinogen abuse (F16.1-); hallucinogen use, unspecified (F16.9-).
What SNOMED CT codes does F16.21 map to?
F16.21 maps to 1 SNOMED CT concept: 191851001. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for F16.21?
F16.21 is linked to 9 UMLS Concept Unique Identifiers: C0154497, C4509072, C4509073, C4509074, C4509075, and 4 more. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.